The role of serum vitamin D levels in vitiligo
dc.authorid | Aktas, Habibullah/0000-0001-9239-1659 | |
dc.authorid | Karagun, Ebru/0000-0002-5032-7429 | |
dc.contributor.author | Karagun, Ebru | |
dc.contributor.author | Ergin, Can | |
dc.contributor.author | Baysak, Sevim | |
dc.contributor.author | Erden, Gonul | |
dc.contributor.author | Aktas, Habibullah | |
dc.contributor.author | Ekiz, Ozlem | |
dc.date.accessioned | 2024-09-29T16:09:38Z | |
dc.date.available | 2024-09-29T16:09:38Z | |
dc.date.issued | 2016 | |
dc.department | Karabük Üniversitesi | en_US |
dc.description.abstract | Introduction: Vitiligo is a common acquired pigmentary skin disorder. Vitamin D is responsible for skin pigmentation, increases tyrosinase activity and melanogenesis, and exhibits immunoregulatory functions. Low levels of vitamin D are associated with many autoimmune diseases, including systemic lupus, diabetes mellitus, rheumatoid arthritis, multiple sclerosis and alopecia areata. Few reports have evaluated serum vitamin D levels in vitiligo patients, and their results are conflicting. Aim: To evaluate serum vitamin D levels of vitiligo patients and compare the results with controls. Material and methods: In total, 50 vitiligo patients and 47 controls were enrolled in the study. Vitamin D levels were measured from blood samples. Group comparisons were performed using appropriate statistical methods. Results: The patients had lower serum vitamin D levels than the controls, but this difference was not significant (p = 0.570). Conclusions: It remains unknown whether vitamin D deficiency causes vitiligo. Larger controlled studies are required to prove whether low circulating vitamin D is a causative factor in vitiligo. | en_US |
dc.identifier.doi | 10.5114/pdia.2016.59507 | |
dc.identifier.endpage | 302 | en_US |
dc.identifier.issn | 1642-395X | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 27605903 | en_US |
dc.identifier.scopus | 2-s2.0-84983436727 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 300 | en_US |
dc.identifier.uri | https://doi.org/10.5114/pdia.2016.59507 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14619/7688 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000382410900011 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Termedia Publishing House Ltd | en_US |
dc.relation.ispartof | Postepy Dermatologii I Alergologii | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | vitiligo | en_US |
dc.subject | vitamin D | en_US |
dc.subject | autoimmune diseases | en_US |
dc.subject | etiopathogenesis | en_US |
dc.title | The role of serum vitamin D levels in vitiligo | en_US |
dc.type | Article | en_US |